Abstract
Progressive multifocal leukoencephalopathy (PML) is an opportunistic viral infection of the human central nervous system. It destroys oligodendrocytes leading to neurological deficits associated with demyelination. It most commonly occurs in HIV-infected patients, but increasing numbers of patients are being recognized in the context of immunosuppressive therapies for autoimmune diseases. The precise pathogenesis of infection by JC virus, a human papovavirus remains elusive, but much has been learned since the original description of the pathologic entity PML in 1958. Detection and diagnosis of this disorder has become more sophisticated with MR imaging of the brain and spinal fluid analysis using polymerase chain reaction (PCR) techniques. Immune reconstitution inflammatory syndrome complicates reversal of immunosuppression when PML has established a foothold in the brain. No effective therapy exists, but there is hope for both better management of patients diagnosed with exogenous immunosuppression and future prospects for antiviral therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aksamit AJ Jr (1993) Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy. Mayo Clin Proc 68(9):899–910
Aksamit AJ Jr (1995) Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis. Microsc Res Tech 32(4):302–311. doi:10.1002/jemt.1070320405
Aksamit AJ (1997) Cerebrospinal fluid in the diagnosis of central nervous system infections. In: Roos KL (ed) Central nervous system infectious diseases and therapy. Marcel Dekker, New York, pp 731–745
Aksamit AJ (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 7(4):386–390. doi:10.1080/13550280152537292
Aksamit AJ (2006) Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist 12(6):293–298. doi:10.1097/01.nrl.0000250948.04681.96
Aksamit AJ (2008) Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 10(3):178–185
Aksamit AJ, Mourrain P, Sever JL, Major EO (1985) Progressive multifocal leukoencephalopathy: investigation of three cases using in situ hybridization with JC virus biotinylated DNA probe. Ann Neurol 18(4):490–496. doi:10.1002/ana.410180412
Aksamit AJ, Sever JL, Major EO (1986) Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry. Neurology 36(4):499–504
Astrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81(1):93–111
Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia-Etxaburu J, Domingo P, Marquez M, Rodriguez-Arrondo FJ, Laguna F, Rubio R, Lacruz Rodrigo J, Mallolas J, de Miguel V (2003) Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 36(8):1047–1052. doi:10.1086/374048
Berger JR (2009) Steroids for PML-IRIS: a double-edged sword? Neurology 72(17):1454–1455. doi:10.1212/01.wnl.0000343735.44983.5e
Berger JR, Houff S (2009) Opportunistic infections and other risks with newer multiple sclerosis therapies. Ann Neurol 65(4):367–377. doi:10.1002/ana.21630
Berger JR, Major EO (1999) Progressive multifocal leukoencephalopathy. Semin Neurol 19(2):193–200. doi:10.1055/s-2008-1040837
Berger JR, Pall L, Lanska D, Whiteman M (1998) Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4(1):59–68. doi:10.3109/13550289809113482
Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, Gerevini S, Bestetti A, Pedale R, Sala S, Lazzarin A, Cinque P (2005) Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 40(5):738–744. doi:10.1086/427698
Bozic C, Richman S, Plavina T, Natarajan A, Scanlon J, Subramanyam M, Sandrock A, Bloomgren G (2011) Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. Ann Neurol 70(5):713–721
Brooks BR, Walker DL (1984) Progressive multifocal leukoencephalopathy. Neurol Clin 2(2):299–313
Calabrese LH, Molloy ES (2008) Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 67(Suppl 3):iii64–65. doi:10.1136/ard.2008.097972
Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the research on adverse drug events and reports project. Blood 113(20):4834–4840. doi:10.1182/blood-2008-10-186999
Castaigne P, Rondot P, Escourolle R, Ribadeau dumas J, Cathala F, Hauw J (1974) Progressive multifocal leukoencephalopathy and multiple gliomas. Rev Neurol 130(9–10):379–392
Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52(3):623–625
Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9(4):438–446. doi:10.1016/S1474-4422(10)70028-4
Clifford D, Nath A, Cinque P, Brew BJ, Workman A, Gorelik L, Zhao J, Duda P (2011a) Mefloquine treatment in patients with progressive multifocal leukoencephalopathy. Neurology 9(4 Suppl):A28
Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL (2011b) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68(9):1156–1164. doi:10.1001/archneurol.2011.103
De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, Monforte A, Antinori A (2001) Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study. J Neurovirol 7(4):364–368
De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, Marra CM, Antinori A (2008) Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 22(14):1759–1767. doi:10.1097/QAD.0b013e32830a5043
Del Valle L, Azizi SA, Krynska B, Enam S, Croul SE, Khalili K (2000) Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme. Ann Neurol 48(6):932–936
Du Pasquier RA, Koralnik IJ (2003) Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol 9(Suppl 1):25–31. doi:10.1080/13550280390195315
Du Pasquier RA, Corey S, Margolin DH, Williams K, Pfister LA, De Girolami U, Mac Key JJ, Wuthrich C, Joseph JT, Koralnik IJ (2003) Productive infection of cerebellar granule cell neurons by JC virus in an HIV + individual. Neurology 61(6):775–782
Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306(5700):1380–1383. doi:10.1126/science.1103492
Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB (1995) Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33(2):484–486
Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51(2):458–469
Gallia GL, Houff SA, Major EO, Khalili K (1997) Review: JC virus infection of lymphocytes—revisited. J Infect Dis 176(6):1603–1609
Geschwind MD, Skolasky RI, Royal WS, McArthur JC (2001) The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J Neurovirol 7(4):353–357. doi:10.1080/13550280152537238
Gibson PE, Knowles WA, Hand JF, Brown DW (1993) Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 39(4):278–281
Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338(19):1345–1351. doi:10.1056/NEJM199805073381903
Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W (1988) Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318(5):301–305. doi:10.1056/NEJM198802043180507
Houston S, Roberts N, Mashinter L (2001) Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus. Clin Infect Dis 32(1):150–152. doi:10.1086/317539
Kast RE, Focosi D, Petrini M, Altschuler EL (2007) Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone. Bone Marrow Transplant 39(12):811–812. doi:10.1038/sj.bmt.1705682
Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353(4):369–374. doi:10.1056/NEJMoa051782
Koralnik IJ (2006) Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 60(2):162–173. doi:10.1002/ana.20933
Korman BD, Tyler KL, Korman NJ (2009) Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol 145(8):937–942. doi:10.1001/archdermatol.2009.175
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353(4):375–381. doi:10.1056/NEJMoa051847
Liu CK, Wei G, Atwood WJ (1998) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2–6)-linked sialic acids. J Virol 72(6):4643–4649
Major EO (2000) From telomeres to T-antigens: many roads…multiple pathways…novel associations in the search for the origins of human gliomas. Ann Neurol 48(6):823–825
Major EO, Amemiya K, Elder G, Houff SA (1990) Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 27(4):461–471. doi:10.1002/jnr.490270405
Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5(1):49–73
Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S (2002) A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16(13):1791–1797
Mateen FJ, Muralidharan R, Carone M, van de Beek D, Harrison DM, Aksamit AJ, Gould MS, Clifford DB, Nath A (2011) Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 70(2):305–322. doi:10.1002/ana.22408
McGuire D, Barhite S, Hollander H, Miles M (1995) JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 37(3):395–399. doi:10.1002/ana.410370316
Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O’Connor PW (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348(1):15–23. doi:10.1056/NEJMoa020696
Nath A, Venkataramana A, Reich DS, Cortese I, Major EO (2006) Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology 66(1):149–150. doi:10.1212/01.wnl.0000191322.93310.a1
Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A (2007) Progressive multifocal leucoencephalopathy in a patient with sarcoidosis–successful treatment with cidofovir and mirtazapine. Rheumatology 46(5):888–890. doi:10.1093/rheumatology/kem049
Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1(7712):1257–1260
Rahmlow M, Shuster EA, Dominik J, Deen HG Jr, Dickson DW, Aksamit AJ Jr, Robles HA, Freeman WD (2008) Leflunomide-associated progressive multifocal leukoencephalopathy. Arch Neurol 65(11):1538–1539. doi:10.1001/archneur.65.11.1538
Razonable RR, Aksamit AJ, Wright AJ, Wilson JW (2001) Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 76(11):1171–1175
Rice GP, Hartung HP, Calabresi PA (2005) Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64(8):1336–1342. doi:10.1212/01.WNL.0000158329.30470.D0
Richardson EP Jr (1961) Progressive multifocal leukoencephalopathy. N Engl J Med 265:815–823. doi:10.1056/NEJM196110262651701
Royal W 3rd, Dupont B, McGuire D, Chang L, Goodkin K, Ernst T, Post MJ, Fish D, Pailloux G, Poncelet H, Concha M, Apuzzo L, Singer E (2003) Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 9(3):411–419. doi:10.1080/13550280390201740
Rudick R, Stuart W, Calabresi P, et al. (2006) Natalizumab plus Interferon Beta-1a for relapsing multiple sclerosis. New England Journal of Medicine 354:911–923
Ryschkewitsch CF, Jensen PN, Monaco MC, Major EO (2010) JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 68(3):384–391. doi:10.1002/ana.22137
Tan K, Roda R, Ostrow L, McArthur J, Nath A (2009) PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72(17):1458–1464. doi:10.1212/01.wnl.0000343510.08643.74
Telenti A, Marshall WF, Aksamit AJ, Smilack JD, Smith TF (1992) Detection of JC virus by polymerase chain reaction in cerebrospinal fluid from two patients with progressive multifocal leukoencephalopathy. Eur J Clin Microbiol Infect Dis 11(3):253–254
Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N Engl J Med 353(4):362–368. doi:10.1056/NEJMoa051586
Viallard JF, Lazaro E, Ellie E, Eimer S, Camou F, Caubet O, Lafon ME, Fleury H, Pellegrin JL (2007) Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis. Infection 35(1):33–36. doi:10.1007/s15010-006-5103-y
Vollmer-Haase J, Young P, Ringelstein EB (1997) Efficacy of camptothecin in progressive multifocal leucoencephalopathy. Lancet 349(9062):1366. doi:10.1016/S0140-6736(05)63201-1
von Einsiedel RW, Fife TD, Aksamit AJ, Cornford ME, Secor DL, Tomiyasu U, Itabashi HH, Vinters HV (1993) Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 240(7):391–406
Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, Bogousslavsky J, Picard F, Landis T, Du Pasquier RA (2006) Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 77(9):1079–1082. doi:10.1136/jnnp.2006.092353
Walker D, Frisque R (1986) The biology and molecular biology of JC virus. In: Salzman NP (ed) The Papovaviridae. Plenum, New York
Weber T, Major EO (1997) Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology 40(2–3):98–111
Weber T, Turner RW, Frye S, Luke W, Kretzschmar HA, Luer W, Hunsmann G (1994) Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 8(1):49–57
Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinstein LJ, Preziosi TJ, Conley FK (1972) Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 286(8):385–390. doi:10.1056/NEJM197202242860801
Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP (1993) Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187(1):233–240
Zurhein G, Chou SM (1965) Particles resembling papova viruses in human cerebral demyelinating disease. Science 148(3676):1477–1479
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Basel
About this chapter
Cite this chapter
Aksamit, A.J. (2013). Progressive Multifocal Leukoencephalopathy. In: Jackson, A. (eds) Viral Infections of the Human Nervous System. Birkhäuser Advances in Infectious Diseases. Springer, Basel. https://doi.org/10.1007/978-3-0348-0425-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0425-7_4
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0424-0
Online ISBN: 978-3-0348-0425-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)